Serotonin Transporter Occupancy in Rats Exposed to Serotonin Reuptake Inhibitors In Utero or via Breast Milk [PDF]
Catherine F. Capello +6 more
openalex +1 more source
Abstract Objective This study was undertaken to evaluate the diagnostic value of a set of preselected candidate microRNAs (miRNAs) extracted from plasma‐based extracellular vesicles (EVs) to identify patients with seizure‐related respiratory dysfunction. Methods A two‐step design was applied.
Sylvain Rheims +11 more
wiley +1 more source
A Review of Neonatal Selective Serotonin Reuptake Inhibitor Withdrawal Syndrome. [PDF]
Mamillapalli L +9 more
europepmc +1 more source
Pindolol augmentation of selective serotonin reuptake inhibitors: Accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression [PDF]
Rebecca Segrave, Pradeep J. Nathan
openalex +1 more source
ABSTRACT Background Prurigo nodularis patients face a significant burden of comorbidities, necessitating a comprehensive approach to care. We aimed to explore the association between prurigo nodularis, its comorbid conditions, and healthcare usage patterns.
Yuliya Valdman‐Grinshpoun +4 more
wiley +1 more source
The selective serotonin reuptake inhibitor escitalopram oxalate negatively impacts the fracture healing in healthy adults and in osteoporotic rats. [PDF]
Carminati Shimano R +7 more
europepmc +1 more source
Age-Dependent Sex Differences in the Prevalence of Selective Serotonin Reuptake Inhibitor Treatment: A Retrospective Cohort Analysis. [PDF]
Sanchez-Ruiz JA +11 more
europepmc +1 more source
Selective serotonin reuptake inhibitors and the risk of bleeding
L Padma +2 more
openalex +2 more sources
Background To examine, using repeated measures, whether prenatal serotonin/norepinephrine reuptake inhibitor (SRI) antidepressant exposure is associated with increased anxious behaviors at kindergarten age and anxiety and/or depression behaviors after kindergarten and into adolescence.
Amanda S. Nitschke +9 more
wiley +1 more source
Beyond Selective Serotonin Reuptake Inhibitor (SSRIs): Exploring Hormonal Therapy for Mood Disorders in Perimenopause and Postmenopause. [PDF]
Mogallapu R +6 more
europepmc +1 more source

